Momelotinib is a highly potent inhibitor of FLT3-mutant AML
Autor: | Azhar, Mohammad, Kincaid, Zachary, Kesarwani, Meenu, Ahmed, Arhama, Wunderlich, Mark, Latif, Tahir, Starczynowski, Daniel, Azam, Mohammad * |
---|---|
Zdroj: | In Blood Advances 22 February 2022 6(4):1186-1192 |
Databáze: | ScienceDirect |
Externí odkaz: |